News | MédiMabs

News

Check out our most recent citations!

24 Sep 2015 by Webmaster MédiMabs

MédiMabs is proud to add new citations for our products:   MM-0008-P (anti-DBH) Novel expression pattern of neuropeptide Y immunoreactivity in the peripheral nervous system in a rat model of neuropathic pain. Claire Magnussen, Shih-Ping Hung and Alfredo Ribeiro-da-Silva. Mol Pain. 2015 May 27;11:31 http://www.ncbi.nlm.nih.gov/pubmed/26012590   MM-0015 (anti-Human Aβ) Stereological estimation of neuron number and plaque load in the hippocampal region of a transgenic rat model of Alzhe »

Read more


Testimonials

24 Sep 2015 by Webmaster MédiMabs

Our customers are our best sales people. See what they have to say about MédiMabs. "I would like to take this opportunity to thank you for the quality of the services you have provided me. I truly feel that yourself and your team have been very efficient and readily available for very good advice. The anti-axin monoclonal antibody that you have produced for me is of very good quality and has become an important tool in our research projects." - Dr. Francois Fagotto, Associate Professor at McGil »

Read more


New Distributors

24 Sep 2015 by Webmaster MédiMabs

MédiMabs is pleased to announce an expansion of its distributor network for its antibody products in the German market with Biomol  and in the USA with Labscoop . MédiMabs has over 20 distributors to support life science research of scientists worldwide. »

Read more


New Species

24 Sep 2015 by Webmaster MédiMabs

MédiMabs now offers development of polyclonal antibodies in both goat & donkey. Development of goat or donkey  antibodies in  is highly advantageous due to their phylogenetic distance from the most common protein species used in research laboratories such as human, mouse and rat, and when large amounts of antiserum are needed.   These animals are pleasant to handle and blood collection is easily achieved via the jugular vein.  Their longer life span allows for collection over a long »

Read more


CCAC Certified Facility

24 Sep 2015 by Webmaster MédiMabs

In April, MédiMabs announced its plans to expand its animal facility. We are now proud to announce that all animal work for the development of antibodies at MédiMabs is done in facilities fully certified by the Canadian Council on Animal Care (CCAC). All of our work is done in here in Québec, Canada allowing for quick processing of samples (blood, sera or supernatants) and rapid delivery to clients.   MédiMabs also has a dedicated team of scientists that are experts in antibody developm »

Read more